A Randomized Single and Multiple Dose Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease.

Trial Profile

A Randomized Single and Multiple Dose Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Dec 2016

At a glance

  • Drugs RPh 201 (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Sponsors Regenera Pharma
  • Most Recent Events

    • 05 Dec 2016 Status changed from recruiting to completed.
    • 23 Dec 2014 Planned End Date changed from 1 Feb 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov .
    • 07 Dec 2012 Planned end date changed from 1 Aug 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top